GHDX - Genomic Health, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue327,868287,458275,706
Cost of Revenue57,26353,78248,742
Gross Profit270,605233,676226,964
Operating Expenses
Research Development61,72359,79853,076
Selling General and Administrative224,314207,905197,515
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-15,432-34,027-23,627
Income from Continuing Operations
Total Other Income/Expenses Net2,894-277-572
Earnings Before Interest and Taxes-12,538-34,304-24,199
Interest Expense---
Income Before Tax-12,538-34,304-24,199
Income Tax Expense1,381-996393
Minority Interest---
Net Income From Continuing Ops-13,919-33,308-24,592
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-13,919-33,308-24,592
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-13,919-33,308-24,592